<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02946476</url>
  </required_header>
  <id_info>
    <org_study_id>OMTrieste</org_study_id>
    <nct_id>NCT02946476</nct_id>
  </id_info>
  <brief_title>Prognostic Impact of Noncardiac Comorbidities in Heart Failure Patients</brief_title>
  <acronym>NCC-HF</acronym>
  <official_title>Prevalence and Prognostic Impact of Noncardiac Comorbidities in Heart Failure Outpatients With Preserved and Reduced Ejection Fraction: A Community-Based Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale Maggiore Di Trieste</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale Maggiore Di Trieste</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To better understand the public health prognostic impact of noncardiac chronic illnesses, we
      explored the attributable risk of noncardiac comorbidities on outcomes between heart failure
      patients with reduced ejection fraction (HFREF) and heart failure patients with preserved
      ejection fraction (HFpEF) in a large contemporary heart failure (HF) population The adjusted
      hazard ratio (HR) and the population attributable risk were used to compare the contributions
      of 15 noncardiac comorbidities to adverse outcome. The comorbidities that contributed to high
      attributable risk were: anemia, chronic kidney disease, chronic obstructive pulmonary
      disease, diabetes mellitus, and peripheral artery disease. These findings were similar for
      HFrEF and HFpEF groups. Interaction analysis confirmed similar results.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>overall mortality</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>First all-cause hospitalization</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Failure hospitalization</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>noncardiovascular hospitalization</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">2314</enrollment>
  <condition>Heart Failure, Diastolic</condition>
  <condition>Heart Failure, Systolic</condition>
  <arm_group>
    <arm_group_label>HFrEF</arm_group_label>
    <description>patients with heart failure and reduced ejection fraction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HFpEF</arm_group_label>
    <description>patients with heart failure and preserved ejection fraction</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>prognostic impact of non cardiac comorbidities</intervention_name>
    <arm_group_label>HFrEF</arm_group_label>
    <arm_group_label>HFpEF</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        We studied all consecutive heart failure patients with diagnostic codes presenting clinical
        findings compatible with heart failure
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All consecutive heart failure patients with left ventricular ejction fraction
             available before or within 3 months from the index visit

        Exclusion Criteria:

          -  We excluded all patients who had severe primary left-sided valvular disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 25, 2016</study_first_submitted>
  <study_first_submitted_qc>October 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2016</study_first_posted>
  <last_update_submitted>October 25, 2016</last_update_submitted>
  <last_update_submitted_qc>October 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale Maggiore Di Trieste</investigator_affiliation>
    <investigator_full_name>Annamaria Iorio</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Failure, Systolic</mesh_term>
    <mesh_term>Heart Failure, Diastolic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

